Table 1 Malaria study proposals submitted to the FTM-EC during the study period
Study characteristic | All studies | Biomedical | Drug trial | Laboratory | Epidemiology | |||||
|---|---|---|---|---|---|---|---|---|---|---|
n = 114 | n = 19 | n = 15 | n = 28 | n = 52 | ||||||
n | % | n | % | n | % | n | % | n | % | |
Types of malaria | ||||||||||
 Plasmodium falciparum | 43 | 37.7 | 4 | 21.1 | 9 | 60.0 | 6 | 21.4 | 24 | 46.2 |
 Plasmodium vivax | 23 | 20.2 | 5 | 26.3 | 3 | 20.0 | 4 | 14.3 | 11 | 21.2 |
 P. falciparum/P. vivax | 23 | 20.2 | 5 | 26.3 | 3 | 20.0 | 7 | 25.0 | 8 | 15.4 |
 Other | 7 | 6.1 | 0 | 0.0 | 0 | 0.0 | 6 | 21.4 | 1 | 1.9 |
 Unspecified | 18 | 15.8 | 5 | 26.3 | 0 | 0.0 | 5 | 17.9 | 8 | 15.4 |
Study type | ||||||||||
 International | 5 | 4.4 | 1 | 5.3 | 1 | 6.7 | 0 | 0.0 | 3 | 5.8 |
 Multi-centre/-site study | 15 | 13.2 | 3 | 15.8 | 8 | 53.3 | 0 | 0.0 | 4 | 7.7 |
 Required other IRB review | 35 | 30.7 | 8 | 42.1 | 11 | 73.3 | 7 | 25.0 | 9 | 17.3 |
Vulnerable subject involvement | ||||||||||
 Minority (border areas) | 32 | 28.1 | 9 | 47.4 | 10 | 66.7 | 7 | 25.0 | 6 | 11.5 |
 Pregnant women | 8 | 7.0 | 1 | 5.3 | 0 | 0.0 | 0 | 0.0 | 7 | 13.5 |
 Children | 19 | 16.7 | 4 | 21.1 | 2 | 13.3 | 7 | 25.0 | 6 | 11.5 |
 Unconscious patients | 2 | 1.8 | 1 | 5.3 | 0 | 0.0 | 0 | 0.0 | 1 | 1.9 |
 Elderly | 2 | 1.8 | 0 | 0.0 | 0 | 0.0 | 1 | 3.6 | 1 | 1.9 |